SCHEMBL4878282

SCHEMBL4878282

c1ccc(-c2cn(-c3ccccn3)c(-c3ccc(-n4ccc5ccccc54)cc3)n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
BIRC5 O15392 1/20 0.43
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PPP1CA P62136 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CDC7 O00311 1/20 0.39
CDK2 P24941 1/20 0.39
ROCK1 Q13464 1/20 0.39
PTGS1 P23219 1/20 0.38
TGFBR1 P36897 2/20 0.37
MGLL Q99685 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
POLB P06746 1/20 0.36
GRM5 P41594 1/20 0.35
FLT3 P36888 1/20 0.34
PTK2 Q05397 1/20 0.34
CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875437 0.86 MAPT (0.47) MAPTBIRC5CYP1A2CYP2C9CYP2C19
SCHEMBL4878767 0.77 MAPT (0.54) MAPTTGFBR1GRM5CYP19A1
SCHEMBL524138 0.76 CDC7 (0.60) MAPTBIRC5CDC7CDK2ROCK1
SCHEMBL29388549 0.76 CDC7 (0.60) MAPTBIRC5CDC7CDK2ROCK1
SCHEMBL31107087 0.76 CDC7 (0.60) MAPTBIRC5CDC7CDK2ROCK1
SCHEMBL31049771 0.75 BIRC5 (0.49) MAPTBIRC5CYP1A2CYP2C9CYP2C19
SCHEMBL4806012 0.75 TGFBR1 (0.44) MAPTCDC7CDK2PTGS1TGFBR1
SCHEMBL4874229 0.75 ALDH1A1 (0.38) MAPTCYP1A2TGFBR1IRAK4POLB
SCHEMBL4859211 0.74 MAPT (0.42) MAPTCDC7CDK2PTGS1GRM5
SCHEMBL4807541 0.74 MAPT (0.43) MAPTCYP1A2CYP2C9CYP2C19PPP1CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PFIZER INC 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090834-A1 SELECTIVE AZOLE PDE10A INHIBITOR COMPOUNDS PDE5A, PDE3B, PDE12 MAPT 964/4885BIRC5 931/4885CYP1A2 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.